PDCD1 and neoplasm: Treatment with anti–PD-1 or anti–PD-L1 alone had no effect, whereas EV treatment induced upregulation of MHC class I and PD-L1 on tumor cells and enhanced tumor infiltration by total immune cells, as well as antigen-specific T cells, indicating a desired immune response.